Published in Bone on November 17, 2009
The amazing osteocyte. J Bone Miner Res (2011) 5.32
Osteocytes: master orchestrators of bone. Calcif Tissue Int (2013) 2.48
The osteocyte: an endocrine cell ... and more. Endocr Rev (2013) 1.84
Suppression of autophagy in osteocytes mimics skeletal aging. J Biol Chem (2013) 1.80
Osteocyte apoptosis. Bone (2012) 1.73
Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation. J Bone Miner Res (2012) 1.56
The role of estrogen and androgen receptors in bone health and disease. Nat Rev Endocrinol (2013) 1.48
Estrogen and the skeleton. Trends Endocrinol Metab (2012) 1.46
Deficiency of circadian clock protein BMAL1 in mice results in a low bone mass phenotype. Bone (2016) 1.41
Osteocyte control of osteoclastogenesis. Bone (2012) 1.36
Osteocyte RANKL: new insights into the control of bone remodeling. J Bone Miner Res (2012) 1.29
Osteocyte regulation of bone mineral: a little give and take. Osteoporos Int (2012) 1.11
Estrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor β. J Biol Chem (2013) 1.11
Alterations in the osteocyte lacunar-canalicular microenvironment due to estrogen deficiency. Bone (2012) 1.00
Deletion of Cx43 from osteocytes results in defective bone material properties but does not decrease extrinsic strength in cortical bone. Calcif Tissue Int (2012) 0.99
Systemic inhibition of canonical Notch signaling results in sustained callus inflammation and alters multiple phases of fracture healing. PLoS One (2013) 0.96
Osteocyte apoptosis is required for production of osteoclastogenic signals following bone fatigue in vivo. Bone (2014) 0.94
Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. Biomed Res Int (2015) 0.92
Osteocyte-derived RANKL is a critical mediator of the increased bone resorption caused by dietary calcium deficiency. Bone (2014) 0.92
For whom the bell tolls: distress signals from long-lived osteocytes and the pathogenesis of metabolic bone diseases. Bone (2012) 0.90
Apoptotic osteocytes and the control of targeted bone resorption. Curr Osteoporos Rep (2014) 0.89
The Effects of Cosmos caudatus on Structural Bone Histomorphometry in Ovariectomized Rats. Evid Based Complement Alternat Med (2012) 0.83
Changes in osteocyte density correspond with changes in osteoblast and osteoclast activity in an osteoporotic sheep model. Osteoporos Int (2011) 0.83
Bone and the innate immune system. Curr Osteoporos Rep (2014) 0.83
Microcracks and osteoclast resorption activity in vitro. Calcif Tissue Int (2012) 0.82
Functions of the osteocyte network in the regulation of bone mass. Cell Tissue Res (2013) 0.82
Estrogens and Androgens in Skeletal Physiology and Pathophysiology. Physiol Rev (2017) 0.81
Inhibition of osteocyte apoptosis prevents the increase in osteocytic receptor activator of nuclear factor κB ligand (RANKL) but does not stop bone resorption or the loss of bone induced by unloading. J Biol Chem (2015) 0.80
Analysis of the effect of osteon diameter on the potential relationship of osteocyte lacuna density and osteon wall thickness. Anat Rec (Hoboken) (2011) 0.78
A Novel, Direct NO Donor Regulates Osteoblast and Osteoclast Functions and Increases Bone Mass in Ovariectomized Mice. J Bone Miner Res (2016) 0.77
Ovariectomy enhances mechanical load-induced solute transport around osteocytes in rat cancellous bone. Bone (2013) 0.77
Mouse models for the evaluation of osteocyte functions. J Bone Metab (2014) 0.77
Pannexin-1 and P2X7-Receptor Are Required for Apoptotic Osteocytes in Fatigued Bone to Trigger RANKL Production in Neighboring Bystander Osteocytes. J Bone Miner Res (2016) 0.76
The RIP1-RIP3 Complex Mediates Osteocyte Necroptosis after Ovariectomy in Rats. PLoS One (2016) 0.76
Oxytocin and bone. Am J Physiol Regul Integr Comp Physiol (2014) 0.76
Regional differences in oxidative metabolism and mitochondrial activity among cortical bone osteocytes. Bone (2016) 0.75
A Convenient In Vivo Model Using Small Interfering RNA Silencing to Rapidly Assess Skeletal Gene Function. PLoS One (2016) 0.75
Cell Death in Chondrocytes, Osteoblasts, and Osteocytes. Int J Mol Sci (2016) 0.75
Disruption of the Cx43/miR21 pathway leads to osteocyte apoptosis and increased osteoclastogenesis with aging. Aging Cell (2017) 0.75
Necrostatin-1 treatment inhibits osteocyte necroptosis and trabecular deterioration in ovariectomized rats. Sci Rep (2016) 0.75
Apoptosis signaling. Annu Rev Biochem (2000) 6.18
Targeted ablation of osteocytes induces osteoporosis with defective mechanotransduction. Cell Metab (2007) 4.64
Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem (2000) 4.36
Mortality after osteoporotic fractures. Osteoporos Int (2003) 3.68
Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J (2005) 3.61
Fas ligand-induced apoptosis. Annu Rev Genet (1999) 3.59
Osteocytes, mechanosensing and Wnt signaling. Bone (2008) 3.57
Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties. Apoptosis (2003) 3.41
The ovariectomized rat model of postmenopausal bone loss. Bone Miner (1991) 3.38
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest (1999) 3.30
Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem (2007) 2.73
Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J (1996) 2.46
Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem (1994) 2.45
A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest (2003) 2.37
Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res (2000) 2.36
Osteocyte apoptosis is induced by weightlessness in mice and precedes osteoclast recruitment and bone loss. J Bone Miner Res (2006) 2.31
Intracortical remodeling in adult rat long bones after fatigue loading. Bone (1998) 2.23
Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip. J Clin Endocrinol Metab (2000) 2.08
The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab (1997) 1.87
Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J Bone Miner Res (2009) 1.84
A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells. J Clin Invest (2004) 1.71
Ovariectomy-induced bone loss varies among inbred strains of mice. J Bone Miner Res (2005) 1.70
In situ measurement of solute transport in the bone lacunar-canalicular system. Proc Natl Acad Sci U S A (2005) 1.68
Genetic variation in bone growth patterns defines adult mouse bone fragility. J Bone Miner Res (2005) 1.66
Delineating bone's interstitial fluid pathway in vivo. Bone (2004) 1.51
Targeted and nontargeted remodeling. Bone (2002) 1.51
Spatial distribution of Bax and Bcl-2 in osteocytes after bone fatigue: complementary roles in bone remodeling regulation? J Bone Miner Res (2002) 1.40
The role of estrogen in the control of rat osteocyte apoptosis. J Bone Miner Res (1998) 1.39
Glutathione metabolism during aging and in Alzheimer disease. Ann N Y Acad Sci (2004) 1.36
Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci U S A (2007) 1.31
Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass. J Bone Miner Res (2006) 1.28
A study of the post-natal growth and remodeling of bone. Am J Anat (1962) 1.26
Apoptotic bodies convey activity capable of initiating osteoclastogenesis and localized bone destruction. J Bone Miner Res (2008) 1.25
Osteocytes use estrogen receptor alpha to respond to strain but their ERalpha content is regulated by estrogen. J Bone Miner Res (2006) 1.25
Identification of apoptotic changes in osteocytes in normal and pathological human bone. Bone (1997) 1.24
Toward a unifying theory of bone remodeling. Bone (2000) 1.19
Genetic background influences cortical bone response to ovariectomy. J Bone Miner Res (2005) 1.14
Bone loss dynamics result in trabecular alignment in aging and ovariectomized rats. J Orthop Res (2006) 1.10
A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo. Neurobiol Dis (2004) 1.06
Novel procedure for high-fidelity tendon histology. J Orthop Res (2007) 1.04
Osteoblast and osteocyte apoptosis associated with androgen action in bone: requirement of increased Bax/Bcl-2 ratio. Bone (2006) 1.04
Strength of cancellous bone trabecular tissue from normal, ovariectomized and drug-treated rats over the course of ageing. Bone (2006) 1.02
Skeletal health: primate model of postmenopausal osteoporosis. Am J Primatol (2009) 1.01
Shortcomings of DXA to assess changes in bone tissue density and microstructure induced by metabolic bone diseases in rat models. Osteoporos Int (2008) 0.99
Effect of fatigue loading and associated matrix microdamage on bone blood flow and interstitial fluid flow. Bone (2007) 0.98
The antioxidant effect of estrogen and Selective Estrogen Receptor Modulators in the inhibition of osteocyte apoptosis in vitro. Bone (2006) 0.96
Response of the osteocyte syncytium adjacent to and distant from linear microcracks during adaptation to cyclic fatigue loading. Bone (2004) 0.95
Estrogen protects primary osteocytes against glucocorticoid-induced apoptosis. Apoptosis (2005) 0.94
Caspase inhibitors reduce neuronal injury after focal but not global cerebral ischemia in rats. Stroke (2000) 0.92
Recovery of trabecular and cortical bone turnover after discontinuation of risedronate and alendronate therapy in ovariectomized rats. J Bone Miner Res (2008) 0.92
Sex hormone-induced alterations in the activities of antioxidant enzymes and lipid peroxidation status in the prostate of Noble rats. Prostate (2003) 0.92
Estradiol inhibits adhesion and promotes apoptosis in murine osteoclasts in vitro. J Steroid Biochem Mol Biol (2006) 0.91
Macrophage migration inhibitory factor-deficient mice are resistant to ovariectomy-induced bone loss. FEBS Lett (2006) 0.90
Hormonal influences on bone remodeling and bone loss: application to the management of primary hyperparathyroidism. Ann Intern Med (1996) 0.89
Quantitative regional associations between remodeling, modeling, and osteocyte apoptosis and density in rabbit tibial midshafts. Bone (2006) 0.89
Osteocyte density in woven bone. Bone (2004) 0.88
Estradiol-17beta protects against hypoxia-induced hepatocyte injury through ER-mediated upregulation of Bcl-2 as well as ER-independent antioxidant effects. Cell Res (2008) 0.88
Mapping bone interstitial fluid movement: displacement of ferritin tracer during histological processing. Bone (2005) 0.88
Effects of treatment with parathyroid hormone 1-84 on quantity and biomechanical properties of thoracic vertebral trabecular bone in ovariectomized rhesus monkeys. Calcif Tissue Int (2008) 0.84
The caspase inhibitor z-VAD is more effective than CD18 adhesion blockade in reducing muscle ischemia-reperfusion injury: implication for clinical trials. Blood (2002) 0.83
Broad spectrum caspase inhibitor rescues retinal ganglion cells after ischemia. Neuroreport (2004) 0.82
Effect of short-term treatment with alendronate on ulnar bone adaptation to cyclic fatigue loading in rats. J Orthop Res (2007) 0.79
Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol (1998) 3.78
The eye-specification proteins So and Eya form a complex and regulate multiple steps in Drosophila eye development. Cell (1997) 3.61
Evaluation of protein multiple alignments by SAM-T99 using the BAliBASE multiple alignment test set. Bioinformatics (2001) 2.92
Regulation in the rpoS regulon of Escherichia coli. Can J Microbiol (1998) 2.68
Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation. J Biol Chem (2001) 2.65
Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma. Endocrinology (1980) 2.46
Bone microdamage and skeletal fragility in osteoporotic and stress fractures. J Bone Miner Res (1997) 2.44
Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone (2001) 2.40
Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo. J Bone Miner Res (2000) 2.36
Cerebral hemispherectomy: hospital course, seizure, developmental, language, and motor outcomes. Neurology (2004) 2.30
Transgastric endoscopic splenectomy: is it possible? Surg Endosc (2006) 2.26
Intracortical remodeling in adult rat long bones after fatigue loading. Bone (1998) 2.23
Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol (2005) 2.18
Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment. Ophthalmology (1993) 2.08
Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann Rheum Dis (2011) 1.97
A model for strain amplification in the actin cytoskeleton of osteocytes due to fluid drag on pericellular matrix. J Biomech (2001) 1.96
Bone remodeling in response to in vivo fatigue microdamage. J Biomech (1985) 1.92
Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone (2001) 1.83
The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas. Int J Cancer (1995) 1.68
Ultrasound for the early diagnosis of tibial fracture healing after static interlocked nailing without reaming: histologic correlation using a canine model. J Orthop Trauma (1998) 1.67
Cyclic hydrostatic pressure enhances the chondrogenic phenotype of human mesenchymal progenitor cells differentiated in vitro. J Orthop Res (2003) 1.67
Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med (1998) 1.64
The role of carbon dioxide insufflation in colonoscopy: a systematic review and meta-analysis. Endoscopy (2012) 1.55
Understanding bone strength: size isn't everything. Bone (2001) 1.53
Vitreous levels of erythropoietin in patients with macular oedema secondary to retinal vein occlusions: a comparative study with diabetic macular oedema. Eye (Lond) (2008) 1.51
Variations in three-dimensional cancellous bone architecture of the proximal femur in female hip fractures and in controls. J Bone Miner Res (2000) 1.50
Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase. J Virol (1996) 1.50
Cataractogenesis after Cobalt-60 eye plaque radiotherapy. Int J Radiat Oncol Biol Phys (1993) 1.49
Neurobeachin: A protein kinase A-anchoring, beige/Chediak-higashi protein homolog implicated in neuronal membrane traffic. J Neurosci (2000) 1.46
The effect of 1,25(OH)2D3 on alkaline phosphatase in osteoblastic osteosarcoma cells. J Biol Chem (1982) 1.45
Studies on matrix vesicles isolated from chick epiphyseal cartilage. Association of pyrophosphatase and ATPase activities with alkaline phosphatase. Biochim Biophys Acta (1975) 1.44
Damage type and strain mode associations in human compact bone bending fatigue. J Orthop Res (1998) 1.41
Recent advances in molecular targets and treatment of idiopathic pulmonary fibrosis: focus on TGFbeta signaling and the myofibroblast. Curr Med Chem (2009) 1.39
Activation of bone remodeling after fatigue: differential response to linear microcracks and diffuse damage. Bone (2010) 1.39
The expression of cytokine activity by fracture callus. J Bone Miner Res (1995) 1.39
In vivo diffuse damage in human vertebral trabecular bone. Bone (2000) 1.35
Expression, phosphorylation and nuclear localization of the human P1 protein, a homologue of the yeast Mcm 3 replication protein. J Cell Sci (1995) 1.34
Osteoporosis induced in mice by overproduction of interleukin 4. Proc Natl Acad Sci U S A (1993) 1.33
Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis (2008) 1.32
Translational enhancement of FGF-2 by eIF-4 factors, and alternate utilization of CUG and AUG codons for translation initiation. Oncogene (1995) 1.31
Cobalt induces heme oxygenase-1 expression by a hypoxia-inducible factor-independent mechanism in Chinese hamster ovary cells: regulation by Nrf2 and MafG transcription factors. J Biol Chem (2001) 1.30
Parathyroid hormone enhances fracture healing. A preliminary report. Clin Orthop Relat Res (1999) 1.28
The involvement of subchondral mineralized tissues in osteoarthrosis: quantitative microscopic evidence. Microsc Res Tech (1997) 1.27
Incidence of dysplasia and carcinoma of the uterine cervix in an Appalachian population. J Natl Cancer Inst (1992) 1.26
Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2. J Med Genet (2004) 1.25
Detection of a monocyte/macrophage differentiation antigen in routinely processed paraffin-embedded tissues by monoclonal antibody Ki-M1P. Lab Invest (1991) 1.24
Genetic immunization for the melanoma antigen MART-1/Melan-A using recombinant adenovirus-transduced murine dendritic cells. Cancer Res (1997) 1.22
Treatment of non-resectable malignant iris tumours with custom designed plaque radiotherapy. Br J Ophthalmol (1995) 1.20
Glucocorticoid regulation of alkaline phosphatase in the osteoblastic osteosarcoma cell line ROS 17/2.8. Endocrinology (1985) 1.20
Role of glycosylation and deglycosylation in biosynthesis of and resistance to oleandomycin in the producer organism, Streptomyces antibioticus. J Bacteriol (1992) 1.20
In vivo trabecular microcracks in human vertebral bone. Bone (1996) 1.20
Dynamin 2 mediates PDGFRα-SHP-2-promoted glioblastoma growth and invasion. Oncogene (2011) 1.18
Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies. Obstet Gynecol (1986) 1.17
Noninvasive fatigue fracture model of the rat ulna. J Orthop Res (2003) 1.17
Failure mechanisms in human vertebral cancellous bone. Bone (1994) 1.17
Modulation of T-cell responses to alloantigens by TR6/DcR3. J Clin Invest (2001) 1.16
Changes in cochlear antioxidant enzyme activity after sound conditioning and noise exposure in the chinchilla. Hear Res (1998) 1.16
Probing the tissue to subcellular level structure underlying bone's molecular sieving function. Biorheology (2003) 1.16
Decline in osteocyte lacunar density in human cortical bone is associated with accumulation of microcracks with age. Bone (2000) 1.16
Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen. Proc Natl Acad Sci U S A (2001) 1.14
Altered expression of genes involved in regulation of vitamin A metabolism, solute transportation, and cytoskeletal function in the androgen-insensitive tfm mouse testis. Endocrinology (2007) 1.14
Attachment of osteocyte cell processes to the bone matrix. Anat Rec (Hoboken) (2009) 1.13
Protein release profiles and morphology of biodegradable microcapsules containing an oily core. J Control Release (2001) 1.13
Virus-like particles as a rotavirus subunit vaccine. J Infect Dis (1996) 1.12
Composition of the cement line and its possible mechanical role as a local interface in human compact bone. J Biomech (1988) 1.12
A murine skeletal adaptation that significantly increases cortical bone mechanical properties. Implications for human skeletal fragility. J Clin Invest (1993) 1.11
Hammerhead ribozyme structure and function in plant RNA replication. Methods Enzymol (2001) 1.11
Evaluation of the transurethral ethanol ablation of the prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation. Eur Urol (2004) 1.10
Regulation of spontaneous phasic firing of rat supraoptic vasopressin neurones in vivo by glutamate receptors. J Physiol (1995) 1.09
Bone and cartilage formation in an experimental model of distraction osteogenesis. J Orthop Trauma (1998) 1.08
Rapid eye movement sleep deprivation selectively impairs recall of fear extinction in hippocampus-independent tasks in rats. Neuroscience (2006) 1.08
Regression of retinoblastoma after plaque radiotherapy. Am J Ophthalmol (1993) 1.08
Persistent working memory dysfunction following traumatic brain injury: evidence for a time-dependent mechanism. Neuroscience (2009) 1.07
Type-I collagen mutation compromises the post-yield behavior of Mov13 long bone. J Orthop Res (1996) 1.07
Feasibility of therapeutic pneumoperitoneum in a large animal model using a microvaporisator. Surg Endosc (2000) 1.06
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease. Neurology (2011) 1.06
Birth defects among children born to a population occupationally exposed to pesticides in Colombia. Scand J Work Environ Health (1990) 1.05
Resistive wall mode instability at intermediate plasma rotation. Phys Rev Lett (2010) 1.05
Rim1 and rabphilin-3 bind Rab3-GTP by composite determinants partially related through N-terminal alpha -helix motifs. J Biol Chem (2001) 1.04
Extreme hypermagnesemia caused by an overdose of magnesium-containing cathartics. Ann Emerg Med (1988) 1.04
A soluble thymic stromal lymphopoietin (TSLP) antagonist, TSLPR-immunoglobulin, reduces the severity of allergic disease by regulating pulmonary dendritic cells. Clin Exp Immunol (2011) 1.03
Differential diagnosis of small single solid thyroid nodules using real-time ultrasound elastography. J Int Med Res (2010) 1.03
Blindness associated with preeclampsia and eclampsia. Am J Obstet Gynecol (1995) 1.02
Strength of cancellous bone trabecular tissue from normal, ovariectomized and drug-treated rats over the course of ageing. Bone (2006) 1.02
The impact of household transmission on duration of outpatient colonization with methicillin-resistant Staphylococcus aureus. Epidemiol Infect (2010) 1.01
Identification of genes required for Drosophila eye development using a phenotypic enhancer-trap. Proc Natl Acad Sci U S A (1997) 1.01
Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins. J Biol Chem (1998) 1.01
Human islet transplantation: update. World J Surg (2001) 1.01
Alkaline phosphatase inhibition by parathyroid hormone and isoproterenol in a clonal rat osteosarcoma cell line. Possible mediation by cyclic AMP. Calcif Tissue Int (1982) 1.00
Type I collagen mutation alters the strength and fatigue behavior of Mov13 cortical tissue. J Biomech (1998) 0.99
Association of the epithelial sodium channel with Apx and alpha-spectrin in A6 renal epithelial cells. J Biol Chem (1999) 0.99
Sequential processing of hepatitis C virus core protein by host cell signal peptidase and signal peptide peptidase: a reassessment. J Viral Hepat (2009) 0.98
Chondrocyte apoptosis in endochondral ossification of chick sterna. Dev Dyn (1995) 0.97
p53 selective and nonselective replication of an E1B-deleted adenovirus in hepatocellular carcinoma. Cancer Res (1999) 0.97
Relationship between quality of life and occupational stress among teachers. Public Health (2009) 0.96
The vitamin D response element-binding protein. A novel dominant-negative regulator of vitamin D-directed transactivation. J Biol Chem (2000) 0.96